Anti-Endomucin抗体[V.7C7.1] (ab106100)
Key features and details
- Rat monoclonal [V.7C7.1] to Endomucin
- Suitable for: IHC-Fr, IHC-P, IP, Flow Cyt, WB, IHC - Wholemount, ICC/IF
- Reacts with: Mouse
- Isotype: IgG2a
概述
-
产品名称
Anti-Endomucin抗体[V.7C7.1]
参阅全部 Endomucin 一抗 -
描述
大鼠单克隆抗体[V.7C7.1] to Endomucin -
宿主
Rat -
经测试应用
适用于: IHC-Fr, IHC-P, IP, Flow Cyt, WB, IHC - Wholemount, ICC/IFmore details
不适用于: FuncS -
种属反应性
与反应: Mouse
不与反应: Human -
免疫原
Other Immunogen Type corresponding to Mouse Endomucin. Mouse endomucin-IgG fusion protein
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
存储溶液
Preservative: 0.02% Sodium azide
Constituents: 0.1% BSA, PBS -
Concentration information loading...
-
纯度
Protein G purified -
纯化说明
0.2 µm filtered solution -
克隆
单克隆 -
克隆编号
V.7C7.1 -
同种型
IgG2a -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab106100于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
IHC-Fr |
Use at an assay dependent concentration.
|
|
IHC-P | (4) |
Use at an assay dependent concentration.
|
IP |
Use at an assay dependent concentration.
|
|
Flow Cyt |
Use at an assay dependent concentration.
ab18450 - Rat monoclonal IgG2a, is suitable for use as an isotype control with this antibody. |
|
WB |
Use at an assay dependent concentration.
|
|
IHC - Wholemount | (1) |
Use at an assay dependent concentration.
|
ICC/IF |
Use a concentration of 1 µg/ml.
|
说明 |
---|
IHC-Fr
Use at an assay dependent concentration. |
IHC-P
Use at an assay dependent concentration. |
IP
Use at an assay dependent concentration. |
Flow Cyt
Use at an assay dependent concentration. ab18450 - Rat monoclonal IgG2a, is suitable for use as an isotype control with this antibody. |
WB
Use at an assay dependent concentration. |
IHC - Wholemount
Use at an assay dependent concentration. |
ICC/IF
Use a concentration of 1 µg/ml. |
靶标
-
功能
Endothelial sialomucin, also called endomucin or mucin-like sialoglycoprotein, which interferes with the assembly of focal adhesion complexes and inhibits interaction between cells and the extracellular matrix. -
组织特异性
Expressed in heart, kidney and lung. -
翻译后修饰
Highly O-glycosylated. Sialic acid-rich glycoprotein. -
细胞定位
Secreted and Cell membrane. Membrane. Consistently localized to the plasma membrane and less abundantly to Golgi-like perinuclear stacks. - Information by UniProt
-
数据库链接
- Entrez Gene: 59308 Mouse
- SwissProt: Q9R0H2 Mouse
- Unigene: 27343 Mouse
-
别名
- EMCN antibody
- EMCN2 antibody
- Endomucin 2 antibody
see all
图片
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (57)
ab106100 被引用在 57 文献中.
- Himmels P et al. T cell-dependent bispecific antibodies alter organ-specific endothelial cell-T cell interaction. EMBO Rep 24:e55532 (2023). PubMed: 36621885
- Tang AT et al. Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection. PLoS Biol 21:e3001989 (2023). PubMed: 36745682
- Wu X et al. Generation of Conditional Knockout Alleles for PRUNE-1. Cells 12:N/A (2023). PubMed: 36831191
- Zhou T et al. Spatiotemporal Characterization of Human Early Intervertebral Disc Formation at Single-Cell Resolution. Adv Sci (Weinh) 10:e2206296 (2023). PubMed: 36965031
- Panebianco C et al. Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model. Cell Death Discov 9:116 (2023). PubMed: 37019893